CTI BioPharma Investor

CTI BioPharma is a biopharmaceutical company developing oncology products for the treatment of cancer.

Invests into

Industry: Biotechnology
Headquarters: Seattle, Washington, United States
Founded Date: 1991
Investor Type: For Profit
Estimated Revenue: $1M to $10M
Visit Website
http://twitter.com/CTIBioPharma
Register and Claim Ownership